Antimicrobial-Associated QT Interval Prolongation: Pointes of Interest
Open Access
- 15 December 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (12), 1603-1611
- https://doi.org/10.1086/508873
Abstract
Until recently, cardiac toxicity manifesting in the form of arrhythmias related to QT interval prolongation was uncommonly appreciated within the antKeywords
This publication has 79 references indexed in Scilit:
- Voriconazole Therapeutic Drug MonitoringAntimicrobial Agents and Chemotherapy, 2006
- Drugs, QTc Interval Prolongation and Final ICH E14 GuidelineDrug Safety, 2005
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Pharmacogenetic Aspects of Drug-Induced Torsade de PointesDrug Safety, 2004
- QT Prolongation with Antimicrobial AgentsDrugs, 2004
- Adverse Drug Reactions Related to the Use of Fluoroquinolone AntimicrobialsDrug Safety, 2003
- Clinical Significance of the Cytochrome P450 2C19 Genetic PolymorphismClinical Pharmacokinetics, 2002
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- Systemic Antifungal AgentsDrug Safety, 1998
- Torsade de PointesDrugs, 1994